TRPV1 and breast cancer: The MCF7 breast cancer cell line, although it expresses endogeneously low levels of TRPV1 receptors, cannot be subjected to necrotic-like procecesses by administration of CAP or RTX, but shows the typical structural changes when TRPV1 is ectopically overexpressed (Figure 2).